Richard H. J. Beǵent

CRUK Lung Cancer Centre of Excellence — United Kingdom

Medicine · Health Sciences

52h-index9.3kcitations227works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(86), Radiopharmaceutical Chemistry and Applications(62), Glycosylation and Glycoproteins Research(35), Testicular diseases and treatments(28), Gestational Trophoblastic Disease Studies(28)

Publications226 total

Kenneth Dawson Bagshawe. 17 August 1925—27 December 2022
Biographical Memoirs of Fellows of the Royal Society·2024Open Access
Ken Bagshawe: physician, scientist, and innovator in medical oncology
BMJ·2023
Radioimmunolocalisation of Cerebral Tumours
Progress in tumor research·2015· 1 cited
Characterisation by nonlinear mixed effects modelling of variability of radiopharmaceutical retention in blood for 131I-CHT25 molecular radiotherapy.
2014
IBC’s 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society
mAbs·2013· 18 citedOpen Access
IBC’s 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society
mAbs·2012Open Access
IBC’s 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5–8, 2011, San Diego, CA
mAbs·2012· 23 citedOpen Access
Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy
BMC Research Notes·2012· 3 citedOpen Access
Establishing a knowledge trail from molecular experiments to clinical trials
New Biotechnology·2011· 2 cited
Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
Angiogenesis·2011· 36 cited
Best Use of Experimental Data in Cancer Informatics
Future Oncology·2010· 3 cited
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
British Journal of Cancer·2010· 193 citedOpen Access
Observations and hypothesis on an individual patient topically treated for capecitabine-induced Palmar-Plantar syndrome: Figure 1
BMJ Case Reports·2010· 2 cited
Antibody-Dependent Enzyme Prodrug Therapy (ADEPT)
2010· 3 cited
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma
Clinical Cancer Research·2009· 44 citedOpen Access
Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells
Biomaterials·2009· 80 cited
From practice guidelines to clinical decision support: closing the loop
Journal of the Royal Society of Medicine·2009· 45 citedOpen Access
Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake
Nuclear Medicine and Biology·2009· 20 citedOpen Access
Imaging in targeted delivery of therapy to cancer
Targeted Oncology·2009· 23 cited
Oncology Information Exchange opens up databases
The Lancet Oncology·2009
page 1 of 12Next →

Frequent Co-authors

Kerry Chester(17), Gordon Rustin(14), G Boxer(10), E.S. Newlands(9), K. D. Bagshawe(8), RB Pedley(8), Berend Tolner(7), L. Holden(6), P A Keep(6), R Boden(6), Surinder K. Sharma(6), L. Robson(5), Caroline J. Springer(5), Daniel Hochhauser(4), K D Bagshawe(4), Geoffrey M. Boxer(4), Aiden Flynn(4), ES Newlands(3), Mark Napier(3), A. J.W. Hilson(3)